Exploiting PP2A dependent and independent effects of forskolin for therapeutic targeting of KMT2A (MLL)‐rearranged acute leukaemia
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.70158 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Yoana Arroyo-Berdugo und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Health Sciences, University of Roehampton, London, UK. Hauptthemen laut MEDLINE: Myeloid-Lymphoid Leukemia Protein, Protein Phosphatase 2, Leukemia, Myeloid, Acute, Colforsin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leukaemia UK, University of Roehampton, University of Surrey.
Abstract (Originalsprache)
Background and Purpose Activation of Protein Phosphatase 2A (PP2A), via genetic and pharmacologic modulation of SET, has recently being identified as a promising strategy to therapeutically target acute myeloid leukaemia (AML) carrying KMT2A (MLL) chromosomal translocations ( KMT2A ‐r AML). Experimental Approach In this study, we investigated the expression of PP2A subunits and the therapeutic potential of forskolin, a cyclic adenosine monophosphate (cAMP) elevating natural compound that has been reported as a PP2A activator. Key Results Our data show that PPP2CA encoding protein phosphatase 2 catalytic subunit α is abundantly expressed in KMT2A ‐r AML cells. Treatment with forskolin arrests proliferation; induces cell death; represses the expression of MYC , HOXA9 and HOXA10 ; stimulates PP2A activity; and attenuates the activity of ERK1/2 in KMT2A ‐r AML cells. Forskolin increases sensitivity to standard‐of‐care daunorubicin in KMT2A ‐AML cell lines and PDX. Silencing PPP2CA partially rescues the cytotoxic effect of forskolin, stimulates ERK1/2, inhibits GSK3β, and abolishes the forskolin‐mediated repression of c‐ MYC and HOXA10, but it did not affect the potentiation of response to daunorubicin. This effect was also not dependent on increase of cAMP, but it was because of increase in the intracellular accumulation of daunorubicin, through inhibition of drug efflux pump P‐glycoprotein 1 (multidrug resistance protein). Conclusions and Implications In conclusion, our findings highlight a novel mechanism of action for forskolin and support a potential role of this natural compound in combination with current conventional agent daunorubicin in the treatment of KMT2A ‐r AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life and Health Sciences, University of Roehampton, London, UK.
- School of Biomedical Sciences, University of West London, London, UK.
- Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University of London, Uxbridge, UK.
- Centre Genomic Regulation, CRG, Barcelona, Spain.
- CEINGE Biotecnologie Avanzate, Naples, Italy.
- University Pompeu Fabra (UPF), Barcelona, Spain.
ORCID-Profile: Maria Teresa Esposito
Förderung
- Leukaemia UK
- University of Roehampton
- University of Surrey
- Institute of Biomedical Science
Zitieren
APA
Arroyo-Berdugo, Y., Di Mambro, A., Behrends, V., Sahai, M. A., Cozzuto, L., Zollo, I., Ponomarenko, J., Williams, O., Gribben, J., Calle, Y., Patel, B., & Esposito, M. T. (2025). Exploiting PP2A dependent and independent effects of forskolin for therapeutic targeting of KMT2A (MLL)‐rearranged acute leukaemia. British Journal of Pharmacology. https://doi.org/10.1111/bph.70158
Vancouver
Arroyo-Berdugo Y, Di Mambro A, Behrends V, Sahai MA, Cozzuto L, Zollo I, et al. Exploiting PP2A dependent and independent effects of forskolin for therapeutic targeting of KMT2A (MLL)‐rearranged acute leukaemia. British Journal of Pharmacology. 2025. doi:10.1111/bph.70158
BibTeX
@article{ArroyoBerdugo2025,
author = {Arroyo-Berdugo, Yoana and Di Mambro, Antonella and Behrends, Volker and Sahai, Michelle A and Cozzuto, Luca and Zollo, Immacolata and Ponomarenko, Julia and Williams, Owen and Gribben, John and Calle, Yolanda and Patel, Bela and Esposito, Maria Teresa},
title = {Exploiting PP2A dependent and independent effects of forskolin for therapeutic targeting of KMT2A (MLL)‐rearranged acute leukaemia},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.70158}
}
EUVIMED